Clinical Fellow Speech-Language Pathologist 2024-2025
Trusted by over 100+ school districts, AnthroMed Education is a therapy group that is dedicated to your success as a Speech Language Pathologist within schools. We are rapidly growing our team of school-based clinicians in Colorado for the 2024-2025 school year and we would love to have you join our team for your CFY.
At AnthroMed we are committed to providing CF-SLPs with the necessary support and resources to be successful in the beginning years of their career.
We are currently interviewing new grads who would be interested in joining our team and working in one of our partner schools in the Aurora area.
Our Process:
Clinical Fellow Support:
AnthroMed has a vast network of wonderful Clinical Fellowship Mentors to match you withBi-weekly team meetings with all SLPs on our teamWe provide regular one-on-one support with our Clinical Support Director for all CFYs.Generous materials stipend for the school year You will be reimbursed for 100% of your ASHA dues and licensure fees in the state of ColoradoOur website: www.AnthroMed.educationAnthroMed offers up to $2,000 relocation assistance for SLPs that are moving to Colorado from out of state!
Qualifications:
Master's Degree in Speech-Language Pathology or Communication Sciences and DisordersExperience as a Graduate Student Clinician in a school setting preferredDesire to work in a team-oriented school setting and a passion for providing quality speech therapy services to studentsAbility to obtain Speech-Language Pathologist licensure through LARAWhen you join AnthroMed Education you will become a salaried employee with 100% free UHC PPO health Insurance, 30-35+ days of PTO, and all school holidays and breaks paid in FULL!
AnthroMed Education is an Equal Opportunity Employer
AnthroMed LLC will not discriminate against any person based on race, sex, sexual orientation, gender, gender identity and expression, height, weight, color, religion, national origin, age, marital status, pregnancy, disability, veteran, or military status. #IND1